Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. (Q51557818)

7 April 2018

title

Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. (English)

1 reference

7 April 2018

0 references

0 references

1 reference

Zein NN

1

1 reference

7 April 2018

Abdulkarim AS

2

1 reference

7 April 2018

Wiesner RH

3

1 reference

7 April 2018

Egan KS

4

1 reference

7 April 2018

Persing DH

5

1 reference

7 April 2018

publication date

1 February 2000

1 reference

7 April 2018

published in

Journal of Hepatology

1 reference

7 April 2018

volume

32

1 reference

7 April 2018

issue

2

1 reference

7 April 2018

page(s)

209-217

1 reference

7 April 2018

Epidemiology of hepatitis C in the West

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Hepatitis C virus in patients with cryoglobulinemia type II.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Mooren-type hepatitis C virus-associated corneal ulceration.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Lichen planus and liver diseases: a multicentre case-control study. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Idiopathic Pulmonary Fibrosis and High Prevalence of Serum Antibodies to Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Diabetes mellitus and the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

High prevalence of hepatitis C virus infection in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

HCV and diabetes mellitus: evidence for a negative association

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Hepatitis G: a virus in search of a disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

The cloning and clinical implications of HGV and HGBV-C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Hepatitis G virus infection: a work in progress

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Hepatitis G infection in drug abusers with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Infection with hepatitis GB virus C in patients on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Effect of hepatitis G virus infection on chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Relative contributions of incidence and survival to increasing prevalence of adult-onset diabetes mellitus: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Glucose metabolism in cirrhosis: a review with some perspectives for the future

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Glucose tolerance and diabetes in chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

The mechanism of the carbohydrate intolerance of cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Glucose metabolism and liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Liver cirrhosis and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Association of diabetes mellitus and chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Liver steatosis and chronic hepatitis C: a spurious association?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Multiple biochemical effects in the pathogenesis of alcoholic fatty liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Review: nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Nonalcoholic Steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

Diabetes mellitus after liver transplantation: prevalence and predictive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980065-3

7 January 2021

10.1016/S0168-8278(00)80065-3

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

10707860

1 reference

7 April 2018